Dentsply Sirona (XRAY) Q2 Sales Drop 5%

Dentsply Sirona (NASDAQ:XRAY), a major player in dental products and technologies, released its second quarter results on August 7, 2025. The company reported GAAP revenue of $936 million and adjusted earnings per share of $0.52. Both figures narrowly beat analyst expectations, which stood at $935.05 million for GAAP revenue and $0.51 for non-GAAP adjusted EPS. Despite margin improvements and Adjusted earnings per share were $0.52 in the second quarter of 2025, compared to $0.49 in the second quarter of 2024, the quarter was overshadowed by a sharp revenue drop of 18.3% in the United States, significant asset impairments (GAAP), and a dramatic slowdown in cash generation. Overall, while the results cleared the low bar of consensus estimates, underlying trends signal persistent challenges for the business. Source: Analyst estimates for the quarter provided by FactSet. Dentsply Sirona designs, manufactures, and sells clinical and digital dental products globally, including imaging equipment, CAD/CAM systems for dental restoration, and a range of consumables such as restorative materials and endodontic tools. Its offerings support dental professionals with technologies like intraoral scanners, 3D printers, and workflow management software.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool